Metraipolis › archive › dc_70af45de8d65
Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates — Europe PMC PMID:41406099
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41406099
- DOI
- 10.1371/journal.pone.0338128
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:58:11.712Z
- SHA-256 of the archived text
892db88d931dbf3309cff5c7e5aeb1e96721ce2c314cbba811960f4116c85cd3- Stable URL of this page
https://metraipolis.com/documento/dc_70af45de8d65
How to cite
Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates — Europe PMC PMID:41406099 — Europe PMC (en), https://europepmc.org/article/MED/41406099 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70af45de8d65 (Metraipolis archive dc_70af45de8d65, sha256 892db88d931dbf3309cff5c7e5aeb1e96721ce2c314cbba811960f4116c85cd3)
BibTeX
@misc{dc70af45de8d65,
title = {Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates — Europe PMC PMID:41406099},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41406099},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70af45de8d65; sha256 892db88d931dbf3309cff5c7e5aeb1e96721ce2c314cbba811960f4116c85cd3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41406099. Agents can read the archived copy with the MCP tool read_document.